These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 32250997)

  • 1. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Shah A; Macdonald GA; Morrison M; Holtmann G
    Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications.
    Maccauro V; Fianchi F; Gasbarrini A; Ponziani FR
    Dig Dis; 2024; 42(4):369-379. PubMed ID: 38527453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
    Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.
    Li ZJ; Gou HZ; Zhang YL; Song XJ; Zhang L
    World J Gastroenterol; 2022 Nov; 28(44):6213-6229. PubMed ID: 36504550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
    Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
    J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Therapeutic Strategies for Primary Sclerosing Cholangitis.
    Williamson KD; Chapman RW
    Semin Liver Dis; 2016 Feb; 36(1):5-14. PubMed ID: 26870928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy.
    Bozward AG; Ronca V; Osei-Bordom D; Oo YH
    Front Immunol; 2021; 12():711217. PubMed ID: 34512631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
    Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
    Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies.
    Özdirik B; Müller T; Wree A; Tacke F; Sigal M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling.
    Schneider KM; Candels LS; Hov JR; Myllys M; Hassan R; Schneider CV; Wahlström A; Mohs A; Zühlke S; Liao L; Elfers C; Kilic K; Henricsson M; Molinaro A; Hatting M; Zaza A; Drasdo D; Frissen M; Devlin AS; Gálvez EJC; Strowig T; Karlsen TH; Hengstler JG; Marschall HU; Ghallab A; Trautwein C
    Nat Metab; 2021 Sep; 3(9):1228-1241. PubMed ID: 34552267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts.
    Özdirik B; Schnabl B
    Cell Mol Gastroenterol Hepatol; 2024; 17(3):423-438. PubMed ID: 38109970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
    Dorner H; Stolzer I; Mattner J; Kaminski S; Leistl S; Edrich LM; Schwendner R; Hobauer J; Sebald A; Leikam S; Gonzalez Acera M; Düll M; Lang R; Seidel G; Seitz T; Hellerbrand C; Fuhrmann G; Distler U; Tenzer S; Eichhorn P; Vieth M; Schramm C; Arnold P; Becker C; Weidinger C; Siegmund B; Atreya R; Leppkes M; Naschberger E; Sampaziotis F; Dietrich P; Rauh M; Wirtz S; Kremer AE; Neurath MF; Günther C
    Gastroenterology; 2024 Nov; 167(6):1183-1197.e16. PubMed ID: 38992449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
    Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
    Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Sitkin S; Pokrotnieks J
    Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
    Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
    Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective function of sclerosing cholangitis on IBD.
    Bedke T; Stumme F; Tomczak M; Steglich B; Jia R; Bohmann S; Wittek A; Kempski J; Göke E; Böttcher M; Reher D; Franke A; Lennartz M; Clauditz T; Sauter G; Fründt T; Weidemann S; Tiegs G; Schramm C; Gagliani N; Pelczar P; Huber S
    Gut; 2024 Jul; 73(8):1292-1301. PubMed ID: 38839272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.